NO20075641L - Kroman og kromenderivater og ders anvendelse - Google Patents

Kroman og kromenderivater og ders anvendelse

Info

Publication number: NO20075641L
Authority: NO; Norway
Prior art keywords: chromium; compounds; derivatives; agonists; subclasses
Prior art date: 2005-04-22

Application number

NO20075641A

Other languages

English (en)

Norwegian (no)

Inventor

Gary Paul Stack

Dahui Zhou

Hong Gao

Gavin David Heffernan

Jonathan Laird Gross

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-22

Filing date

2007-11-06

Publication date

2007-11-20

2007-11-06 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-11-20 Publication of NO20075641L publication Critical patent/NO20075641L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20075641A 2005-04-22 2007-11-06 Kroman og kromenderivater og ders anvendelse NO20075641L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US67382005P	2005-04-22	2005-04-22
PCT/US2006/015208 WO2006116165A1 (en)	2005-04-22	2006-04-21	Chromane and chromene derivatives and uses thereof

Publications (1)

Publication Number	Publication Date
NO20075641L true NO20075641L (no)	2007-11-20

Family

ID=36888961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20075641A NO20075641L (no)	2005-04-22	2007-11-06	Kroman og kromenderivater og ders anvendelse

Country Status (19)

Country	Link
US (2)	US7365095B2 (es)
EP (1)	EP1874756A1 (es)
JP (1)	JP2008538576A (es)
KR (1)	KR20080008378A (es)
CN (1)	CN101203505A (es)
AR (1)	AR056320A1 (es)
AU (1)	AU2006239937A1 (es)
BR (1)	BRPI0610027A2 (es)
CA (1)	CA2605587A1 (es)
CO (1)	CO6321153A2 (es)
GT (1)	GT200600166A (es)
IL (1)	IL186837A0 (es)
MX (1)	MX2007013163A (es)
NO (1)	NO20075641L (es)
PE (1)	PE20061297A1 (es)
RU (1)	RU2007139541A (es)
TW (1)	TW200716595A (es)
WO (1)	WO2006116165A1 (es)
ZA (1)	ZA200709052B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
US20050261347A1 (en) *	2003-10-24	2005-11-24	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7435837B2 (en) *	2003-10-24	2008-10-14	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
GT200500297A (es) *	2004-10-21	2006-10-27		Sintesis asimetrica de dehidrobenzofuranos sustituidos
GT200500296A (es) *	2004-10-21	2006-10-02		Sintesis asimetrica de derivados del dehidrobenzofurano
AR056321A1 (es) *	2005-04-22	2007-10-03	Wyeth Corp	COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
CA2604916A1 (en) *	2005-04-22	2006-11-02	Wyeth	Dihydrobenzofuran derivatives and uses thereof
JP2008536946A (ja) *	2005-04-22	2008-09-11	ワイス	うつ病の処置または予防のための新規の治療的組み合わせ
AU2006239930A1 (en) *	2005-04-22	2006-11-02	Wyeth	Benzodioxane and benzodioxolane derivatives and uses thereof
MX2007013065A (es) *	2005-04-22	2008-01-14	Wyeth Corp	Derivados de dihidrobenzofurano y usos de los mismos.
AU2006239943A1 (en) *	2005-04-22	2006-11-02	Wyeth	Treatment of pain
CA2605554A1 (en) *	2005-04-22	2006-11-02	Wyeth	Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
GT200600165A (es) *	2005-04-22	2007-03-14		Derivados dihidrobenzofuranos y usos de los mismos
AR056320A1 (es) *	2005-04-22	2007-10-03	Wyeth Corp	Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos
JP2008538784A (ja) *	2005-04-24	2008-11-06	ワイス	膀胱機能を調節するための方法
PE20080172A1 (es) *	2006-03-24	2008-04-21	Wyeth Corp	Compuestos dihidrobenzofuranil alcanamida como moduladores del receptor 5-ht2c
TW200815388A (en) *	2006-04-18	2008-04-01	Wyeth Corp	Chromane and chromene derivatives and uses thereof
EP2742936A1 (en)	2006-05-16	2014-06-18	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound and use thereof
CL2007003043A1 (es) *	2006-10-24	2008-05-30	Wyeth Corp	Compuestos derivados de cromano; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y ansiedad entre otros.
TW200831478A (en) *	2006-10-25	2008-08-01	Wyeth Corp	Chromane derivatives, synthesis thereof, and intermediates thereto
CA2695634C (en)	2007-08-06	2018-01-23	Serenity Pharmaceuticals Corporation	Methods and devices for desmopressin drug delivery
US20100266504A1 (en)	2007-11-15	2010-10-21	Takahiro Matsumoto	Condensed pyridine derivative and use thereof
US8914112B2 (en)	2008-01-23	2014-12-16	Boston Scienctific Neuromodulation Corporation	Methods and systems of treating pancreatitis pain caused by sphincter of Oddi dysfunction
US8676322B2 (en)	2008-01-30	2014-03-18	Boston Scientific Neuromodulation Corporation	Methods and systems of treating pancreatitis pain
SG176464A1 (en) *	2008-05-09	2011-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
HUE030409T2 (en)	2008-05-21	2017-05-29	Ferring Bv	Orodispersible desmopressin preparation to increase the length of the initial period of sleep disturbed by nocturia
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
US20120253036A1 (en)	2009-12-11	2012-10-04	Yukinori Nagakura	Agent for treating fibromyalgia
CN101921252B (zh) *	2010-07-02	2012-05-09	中国科学院上海有机化学研究所	1-氧杂苯并杂环类化合物、合成方法和用途
CN103261138B (zh)	2010-12-21	2015-08-12	高露洁-棕榄公司	作为抗菌剂的卤代联苯酚
CN109970533B (zh) *	2012-12-18	2022-06-14	帝斯曼知识产权资产管理有限公司	由(r)-6，10，14-三甲基十五碳-5-烯-2-酮制备的(6r，10r)-6，10，14-三甲基十五烷-2-酮
KR101592560B1 (ko) *	2013-06-21	2016-02-05	제주대학교 산학협력단	신규 플라보노이드 및 그 용도
WO2015066344A1 (en)	2013-11-01	2015-05-07	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists and compositions and methods of use
MX371404B (es)	2015-02-11	2020-01-29	Sunovion Pharmaceuticals Inc	Compuestos y analogos de 1-heterociclil isocromanilo para el tratamiento de trastornos del sistema nervioso central (snc).
EP3494119B1 (en)	2016-07-29	2024-09-04	Sumitomo Pharma America, Inc.	Compounds and compositions and uses thereof
CA3032141A1 (en)	2016-07-29	2018-02-01	Vadim ALEXANDROV	Compounds and compositions and uses thereof
US10780074B2 (en)	2017-08-02	2020-09-22	Sunovion Pharmaceuticals Inc.	Compounds and uses thereof
EP3733204A4 (en)	2017-12-27	2021-09-15	Takeda Pharmaceutical Company Limited	THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE
EP3923919A4 (en) *	2019-02-17	2022-12-07	Neurawell Therapeutics	COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION AND OTHER DISORDERS
MX2021010880A (es)	2019-03-14	2022-01-18	Sunovion Pharmaceuticals Inc	Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas.

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1262078A (en)	1968-05-24	1972-02-02	Fisons Pharmaceuticals Ltd	Preparation of phenoxy fumaric acid compounds and chromone-2-carboxylic acid compounds therefrom
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4654362A (en) *	1983-12-05	1987-03-31	Janssen Pharmaceutica, N.V.	Derivatives of 2,2'-iminobisethanol
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5089637A (en) *	1990-03-21	1992-02-18	Pfizer Inc.	Process and intermediates for 2r-benzyl-chroman-6-carbaldehyde
JP3283114B2 (ja) *	1992-09-07	2002-05-20	クミアイ化学工業株式会社	縮合ヘテロ環誘導体及び農園芸用殺菌剤
US5731324A (en) *	1993-07-22	1998-03-24	Eli Lilly And Company	Glycoprotein IIb/IIIa antagonists
SK282402B6 (sk) *	1993-08-19	2002-01-07	Janssen Pharmaceutica N. V.	Deriváty dihydrobenzopyránu, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutický prostriedok na ich báze
US6150402A (en) *	1994-08-15	2000-11-21	Loma Linda University Medical Center	Natriuretic compounds
DE4430089A1 (de)	1994-08-25	1996-02-29	Bayer Ag	Verfahren zur enzymatischen Herstellung von enantiomerenreinen Chroman-2-carbonsäuren und deren Derivaten
SI0707007T1 (en) *	1994-10-14	2002-04-30	Merck Patent Gmbh	(R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
US5658796A (en) *	1995-06-07	1997-08-19	Seprachem, Inc.	Optical resolution of alkyl chroman-2-carboxylates
HU225960B1 (en) *	1997-02-27	2008-01-28	Takeda Pharmaceutical	Amine compounds, their production and use
FR2763335B1 (fr) *	1997-05-16	2000-11-24	Adir	Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6133277A (en) *	1997-12-05	2000-10-17	Janssen Pharmaceutica N.V.	(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
US20060258176A1 (en) *	1998-02-05	2006-11-16	Asm Japan K.K.	Method for forming insulation film
US6011035A (en) *	1998-06-30	2000-01-04	Neuromed Technologies Inc.	Calcium channel blockers
FR2791675B1 (fr)	1999-03-30	2001-05-04	Synthelabo	Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
DE10044091A1 (de) *	2000-09-07	2002-04-04	Merck Patent Gmbh	Chromanonderivate
UA75898C2 (en) *	2000-11-14	2006-06-15	Merck Patent Gmbh	Method for prophylaxis and treatment of eye diseases using antagonist of integrin receptors
DE10120619A1 (de) *	2001-04-26	2002-10-31	Merck Patent Gmbh	2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman
JP2005504757A (ja) *	2001-08-01	2005-02-17	メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング	眼の疾患の治療用インテグリン阻害剤
WO2003029239A1 (en)	2001-10-04	2003-04-10	Wyeth	Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
JP2005505586A (ja)	2001-10-04	2005-02-24	ワイス	５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体
CA2462860A1 (en) *	2001-10-05	2003-04-17	Wyeth	Stereospecific process for the synthesis of 2-yl chroman derivatives
BR0213127A (pt) *	2001-10-05	2004-09-21	Wyeth Corp	Processo para a sìntese estéreo-seletiva de 2-hidroximetil-cromanos
WO2003031439A1 (en)	2001-10-05	2003-04-17	Wyeth	Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
US20050014818A1 (en) *	2001-11-09	2005-01-20	Masaru Mitsuda	Process for producing optically active chroman derivative and intermediate
US7196108B2 (en) *	2002-03-08	2007-03-27	Incyte San Diego Inc.	Bicyclic heterocycles for the treatment of diabetes and other diseases
US20040097433A1 (en)	2002-11-15	2004-05-20	Sekhar Boddupalli	Chroman derivatives for the reduction of inflammation symptoms
CA2580584C (en)	2003-09-19	2015-07-28	Galileo Pharmaceuticals, Inc.	Use of alpha-tocotrienol for treatment of mitochondrial diseases
DE10348257A1 (de)	2003-10-16	2005-05-25	Merck Patent Gmbh	Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten
US7728155B2 (en) *	2003-10-24	2010-06-01	Wyeth Llc	Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
US20050261347A1 (en) *	2003-10-24	2005-11-24	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7435837B2 (en) *	2003-10-24	2008-10-14	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
DE102004011265A1 (de)	2004-03-09	2005-09-29	Lutz F. Prof. Dr. Tietze	Synthese von Vitamin E
GT200500296A (es) *	2004-10-21	2006-10-02		Sintesis asimetrica de derivados del dehidrobenzofurano
GT200500297A (es) *	2004-10-21	2006-10-27		Sintesis asimetrica de dehidrobenzofuranos sustituidos
US7812019B2 (en)	2004-11-24	2010-10-12	Abbott Laboratories	Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
AR056321A1 (es) *	2005-04-22	2007-10-03	Wyeth Corp	COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
US20060258711A1 (en) *	2005-04-22	2006-11-16	Wyeth	Treatment of drug abuse
JP2008536946A (ja) *	2005-04-22	2008-09-11	ワイス	うつ病の処置または予防のための新規の治療的組み合わせ
CA2605554A1 (en) *	2005-04-22	2006-11-02	Wyeth	Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
MX2007013065A (es) *	2005-04-22	2008-01-14	Wyeth Corp	Derivados de dihidrobenzofurano y usos de los mismos.
JP2008538581A (ja) *	2005-04-22	2008-10-30	ワイス	｛［（２ｒ）−７−（２，６−ジクロロフェニル）−５−フルオロ−２，３−ジヒドロ−１−ベンゾフラン−２−イル］メチル｝アミン塩酸塩の結晶形態
GT200600165A (es) *	2005-04-22	2007-03-14		Derivados dihidrobenzofuranos y usos de los mismos
AU2006239943A1 (en) *	2005-04-22	2006-11-02	Wyeth	Treatment of pain
AR056320A1 (es) *	2005-04-22	2007-10-03	Wyeth Corp	Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos
AU2006239930A1 (en) *	2005-04-22	2006-11-02	Wyeth	Benzodioxane and benzodioxolane derivatives and uses thereof
JP2008538784A (ja) *	2005-04-24	2008-11-06	ワイス	膀胱機能を調節するための方法

2006
- 2006-04-21 AR ARP060101590A patent/AR056320A1/es unknown
- 2006-04-21 EP EP06758490A patent/EP1874756A1/en not_active Withdrawn
- 2006-04-21 CA CA002605587A patent/CA2605587A1/en not_active Abandoned
- 2006-04-21 GT GT200600166A patent/GT200600166A/es unknown
- 2006-04-21 AU AU2006239937A patent/AU2006239937A1/en not_active Abandoned
- 2006-04-21 CN CNA2006800222674A patent/CN101203505A/zh active Pending
- 2006-04-21 PE PE2006000415A patent/PE20061297A1/es not_active Application Discontinuation
- 2006-04-21 MX MX2007013163A patent/MX2007013163A/es unknown
- 2006-04-21 KR KR1020077027247A patent/KR20080008378A/ko not_active Application Discontinuation
- 2006-04-21 JP JP2008507952A patent/JP2008538576A/ja active Pending
- 2006-04-21 WO PCT/US2006/015208 patent/WO2006116165A1/en active Application Filing
- 2006-04-21 US US11/409,467 patent/US7365095B2/en not_active Expired - Fee Related
- 2006-04-21 RU RU2007139541/04A patent/RU2007139541A/ru unknown
- 2006-04-21 TW TW095114313A patent/TW200716595A/zh unknown
- 2006-04-21 BR BRPI0610027-9A patent/BRPI0610027A2/pt not_active Application Discontinuation
2007
- 2007-10-19 ZA ZA200709052A patent/ZA200709052B/xx unknown
- 2007-10-22 IL IL186837A patent/IL186837A0/en unknown
- 2007-10-22 CO CO07110959A patent/CO6321153A2/es not_active Application Discontinuation
- 2007-11-06 NO NO20075641A patent/NO20075641L/no not_active Application Discontinuation
2008
- 2008-03-19 US US12/051,368 patent/US20080182891A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20060258714A1 (en)	2006-11-16
RU2007139541A (ru)	2009-05-27
US20080182891A1 (en)	2008-07-31
US7365095B2 (en)	2008-04-29
EP1874756A1 (en)	2008-01-09
CO6321153A2 (es)	2011-09-20
AU2006239937A1 (en)	2006-11-02
MX2007013163A (es)	2008-01-21
CN101203505A (zh)	2008-06-18
CA2605587A1 (en)	2006-11-02
ZA200709052B (en)	2009-08-26
BRPI0610027A2 (pt)	2010-05-18
WO2006116165A1 (en)	2006-11-02
JP2008538576A (ja)	2008-10-30
PE20061297A1 (es)	2006-12-24
GT200600166A (es)	2007-03-14
TW200716595A (en)	2007-05-01
KR20080008378A (ko)	2008-01-23
AR056320A1 (es)	2007-10-03
IL186837A0 (en)	2008-02-09

Publication	Publication Date	Title
NO20075641L (no)	2007-11-20	Kroman og kromenderivater og ders anvendelse
NO20062139L (no)	2006-07-21	Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
NO20063620L (no)	2006-10-06	Arylanilinderivater som beta2 adrenergiske receptoragonister
NO20064201L (no)	2006-12-13	Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
TW200720266A (en)	2007-06-01	Benzodioxane and benzodioxolan derivatives and uses thereof
NO20091893L (no)	2009-07-09	Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
TW200718692A (en)	2007-05-16	Dihydrobenzofuran derivatives and uses thereof
NO20083434L (no)	2008-08-12	Benzamid- og heteroarenderivater
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
DE60315674D1 (de)	2007-09-27	Neue imidazopyridine und ihre verwendung
MX2007013021A (es)	2008-01-11	Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
NO20084845L (no)	2009-02-03	2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
CR10419A (es)	2011-07-19	Derivados de Pirazolo [3,4-D]-Pirimidina útiles para tratar trastornos respiratorios
NO20085257L (no)	2009-01-19	Purinonderivater som HM74a-agonister
MY155836A (en)	2015-12-15	Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
WO2008148867A3 (en)	2009-04-09	Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
NO20084872L (no)	2009-02-03	2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
ATE482210T1 (de)	2010-10-15	Oxadiazolderivate als s1p1-rezeptor-agonisten
DK1697371T3 (da)	2007-09-17	Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
NO20076695L (no)	2008-02-28	Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20080670L (no)	2008-04-01	Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
NO20074781L (no)	2007-09-19	4-Oksokinazolin-3-ylbenzamidderivater for behandling av cytokinsykdommer
NO20051263L (no)	2005-05-12	Ny anvendelse av benzotiazolderivater
NO20083058L (no)	2008-10-09	Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
NO20082112L (no)	2008-06-23	3-Amino-2-arylpropylazaindoler og deres anvendelse

Legal Events

Date	Code	Title	Description
2009-11-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application